QW30
QW30 (Compound 19) shows potent antitumor activity with an IC50 value of 0.33 μM.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 1714112-25-0
- 화학식: C27H36N2O3
- 분자량:436.59
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DU-145 | IC50 |
0.28 μM
Compound: 19; QW30
|
Antiproliferative activity against human DU145 cells after 96 hrs by SRB assay
Antiproliferative activity against human DU145 cells after 96 hrs by SRB assay
|
[PMID: 27187855] |
| HCT-116 | IC50 |
0.57 μM
Compound: 19; QW30
|
Antiproliferative activity against human HCT116 cells after 96 hrs by SRB assay
Antiproliferative activity against human HCT116 cells after 96 hrs by SRB assay
|
[PMID: 27187855] |
| HL-60 | IC50 |
0.04 μM
Compound: 19; QW30
|
Antiproliferative activity against human HL60 cells after 96 hrs by SRB assay
Antiproliferative activity against human HL60 cells after 96 hrs by SRB assay
|
[PMID: 27187855] |
| HT-29 | IC50 |
0.59 μM
Compound: 19; QW30
|
Antiproliferative activity against human HT-29 cells after 96 hrs by SRB assay
Antiproliferative activity against human HT-29 cells after 96 hrs by SRB assay
|
[PMID: 27187855] |
| MCF7 | IC50 |
0.28 μM
Compound: 19; QW30
|
Antiproliferative activity against human MCF7 cells after 96 hrs by SRB assay
Antiproliferative activity against human MCF7 cells after 96 hrs by SRB assay
|
[PMID: 27187855] |
| MDA-MB-231 | IC50 |
0.32 μM
Compound: 19; QW30
|
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by SRB assay
Antiproliferative activity against human MDA-MB-231 cells after 96 hrs by SRB assay
|
[PMID: 27187855] |
| PC-3 | IC50 |
0.54 μM
Compound: 19; QW30
|
Antiproliferative activity against human PC3 cells after 96 hrs by SRB assay
Antiproliferative activity against human PC3 cells after 96 hrs by SRB assay
|
[PMID: 27187855] |
| T47D | EC50 |
2.56 nM
Compound: 19; QW30
|
Inhibition of colony formation in human T47D cells after 7 days by crystal violet staining based assay
Inhibition of colony formation in human T47D cells after 7 days by crystal violet staining based assay
|
[PMID: 27187855] |
| T47D | EC50 |
6.42 μM
Compound: 19; QW30
|
Antimigratory activity in human T47D cells assessed as inhibition of cell migration after 12 hrs by crystal violet staining based transwell migration assay
Antimigratory activity in human T47D cells assessed as inhibition of cell migration after 12 hrs by crystal violet staining based transwell migration assay
|
[PMID: 27187855] |
| T47D | IC50 |
0.01 μM
Compound: 19; QW30
|
Antiproliferative activity against human T47D cells after 96 hrs by SRB assay
Antiproliferative activity against human T47D cells after 96 hrs by SRB assay
|
[PMID: 27187855] |
Chemical Information
-
CAS No. 1714112-25-0
-
분자량 436.59
-
화학식 C27H36N2O3
-
SMILES
CC1(C)[C@@H](O)CC[C@]2(C)C3=C(C=C(C(NC4=CC=C(N(C)C)C=C4)=O)C(OC)=C3)CC[C@@]12[H]
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocol
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
순도&문서
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)